"BL Science, a subsidiary of BL Pharmtech, said on Thursday that it signed an agreement with Kumoh National Institute of Technology, a local university, to jointly develop a cancer diagnosis solution utilizing artificial intelligence (AI) in tissue and cellular pathology diagnosis."